← Eichor
Study identifier: NCT06789484 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Characterization of the Gastrointestinal Microbiota in Newborn Infants

Condition: Healthy Infants  ·  Sponsor: Hvidovre University Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, N/A to 1 Day
Healthy volunteersYes

About this study

The BABIES study is a single-center, randomized, double-blinded, placebo-controlled study in newborns with a 4-week intervention period from birth to 28 days of life followed by a 2-week follow-up period (Figure 1). The study will evaluate the seeding ability of supplementation with a probiotic strain. The aim is to investigate the recovery and engraftment of the probiotic strain in infant fecal samples after 4 weeks supplementation using a strain specific quantitative Polymerase Chain Reaction (qPCR).

This description comes directly from the study's public registry record.

Talk to the study team

Sofie Ingdam Halkjær, MSc, PhD  ·  +4541318174  ·  sofie.ingdam.halkjaer@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Center for Klinisk Mikrobiom Forskning, Gastroenheden og Klinisk Mikrobiologisk AfdelingHvidovre, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06789484